Search Results - "Luber, Raphael"

Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases by Cheifetz, Adam S., MD, Gianotti, Robert, MD, Luber, Raphael, MD, Gibson, Peter R., MD

“…Abstract Patients and physicians often have many questions regarding the role of complementary and alternative medicines (CAMs), or non-allopathic therapies,…”
Get full text

Editorial: establishing a joint approach to a common problem for gastroenterologists by Luber, Raphael P., Irving, Peter M.

“…LINKED CONTENTThis article is linked to Varkas paper. To view this article, visit https://doi.org/10.1111/apt.15519…”
Get full text

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease by Vasudevan, Abhinav, Parthasarathy, Nina, Con, Danny, Nicolaides, Steven, Apostolov, Ross, Chauhan, Ayushi, Bishara, Maria, Luber, Raphael P., Joshi, Neetima, Wan, Anna, Rickard, James A., Long, Tony, Connoley, Declan, Sparrow, Miles P., Gibson, Peter R., Langenberg, Daniel R.

“…Summary Background There are safety concerns regarding immunomodulators (thiopurines and methotrexate) for treatment of inflammatory bowel disease (IBD). Aim…”
Get full text

Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease by Luber, Raphael P, Dawson, Luke, Munari, Stephanie, Kariyawasam, Viraj C, Martin, Catherine, Gibson, Peter R, Sparrow, Miles P, Ward, Mark G

“…Background and Aim Combining therapy with a thiopurine is favored when commencing infliximab in Crohn's disease; however, the optimal 6‐thioguanine nucleotide…”
Get full text

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre by Meade, Susanna, Patel, Kamal V., Luber, Raphael P., O'Hanlon, Dearbhaile, Caracostea, Andra, Pavlidis, Polychronis, Honap, Sailish, Anandarajah, Cheran, Griffin, Nyree, Zeki, Sebastian, Ray, Shuvra, Mawdsley, Joel, Samaan, Mark A., Anderson, Simon H., Darakhshan, Amir, Adams, Katie, Williams, Andrew, Sanderson, Jeremy D., Lomer, Miranda, Irving, Peter M.

“…Summary Background Low‐quality evidence suggests that pre‐operative exclusive enteral nutrition (E/EN) can improve postoperative outcomes in patients with…”
Get full text

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch by Luber, Raphael P., O'Neill, Rhona, Singh, Sukhpreet, Sharma, Esha, Cunningham, Georgina, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H., Mawdsley, Joel, Sanderson, Jeremy D., Samaan, Mark A., Arkir, Zehra, Irving, Peter M.

“…Summary Background Biologics account for a significant cost in inflammatory bowel disease (IBD) management; however, switching from infliximab originator to…”
Get full text

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease by Rentsch, Clarissa A., Ward, Mark G., Luber, Raphael P., Taylor, Kirstin M., Gibson, David J., Headon, Belinda, Rosella, Ourania, Su, Heidi Y., Friedman, Antony B., Dooley, Michael, Sparrow, Miles P., Gibson, Peter R.

“…Therapeutic monitoring of infliximab is limited by the time lag between drug-level measurement and dose adjustment, along with the cost of dose escalation…”
Get full text

Anogenital Crohn’s Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment by Honap, Sailish, Meade, Susanna, Spencer, Ashley, Pavlidis, Polychronis, Luber, Raphael P, Calonje, Eduardo, Rashidghamat, Ellie, Bunker, Christopher B, Lewis, Fiona, Irving, Peter M

“…Abstract Background and Aims Metastatic Crohn’s disease is an extraintestinal cutaneous manifestation characterised by non-specific inflammatory lesions…”
Get full text

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases? by Luber, Raphael P, Honap, Sailish, Cunningham, Georgina, Irving, Peter M

“…Thiopurines are a cheap, effective treatment option in the management of inflammatory bowel disease (IBD). However, with the growing choice of targeted…”
Get full text

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study by Luber, Raphael P, Duff, Alexa, Pavlidis, Polychronis, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H, Mawdsley, Joel, Samaan, Mark A, Irving, Peter M

“…Background and Aim Patients with chronic diseases are believed to be at increased risk of mental health conditions during the COVID‐19 pandemic. We aimed to…”
Get full text

New onset vitiligo following commencement of infliximab in Crohn disease by Luber, Raphael P., Chamberlain, Alex J., Sparrow, Miles P.

Get full text

Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn’s Disease by Con, Danny, Parthasarathy, Nina, Bishara, Maria, Luber, Raphael P, Joshi, Neetima, Wan, Anna, Rickard, James A, Long, Tony, Connoley, Declan J, Sparrow, Miles P, Gibson, Peter R, van Langenberg, Daniel R, Vasudevan, Abhinav

“…Abstract Background Early or first-line treatment with biologics, as opposed to conventional immunomodulators, is not always necessary to achieve remission in…”
Get full text

Positioning intestinal ultrasound in a UK tertiary centre: significant estimated clinical role and cost savings by Luber, Raphael P, Petri, Bianca, Meade, Susanna, Honap, Sailish, Zeki, Sebastian, Gecse, Krisztina B, Griffin, Nyree, Irving, Peter M

“…ObjectiveIntestinal ultrasound (IUS) is an inexpensive, non-invasive method of diagnosing and monitoring inflammatory bowel disease (IBD). We aimed to…”
Get full text

A Target 6-Thioguanine Nucleotide Level ≥ 125 is Associated with a Higher Rate and Longer Durability of Response in Infliximab-Thiopurine Combination Therapy: A Retrospective Study in Crohn's Disease Patients by Luber, Raphael P, Kariyawasam, Viraj C, Dawson, Luke P, Munari, Stephanie C, Gibson, Peter R, Sparrow, Miles, Ward, Mark G

Get full text

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report by Merrick, Blair, Tamilarasan, Aravind Gokul, Luber, Raphael, Yong, Patrick F. K., Cheent, Kuldeep, Irving, Peter M., Meda, Manjula, Goldenberg, Simon D.

“…There is limited evidence to guide successful treatment of recurrent Campylobacter infection in patients with common variable immunodeficiency (CVID) already…”
Get full text

Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case report by Vaz, Karl, Luber, Raphael P, McLean, Catriona, Gerstenmaier, Jan Frank, Roberts, Stuart K

“…Gastric adenocarcinoma is a known complication of partial gastrectomy. Jaundice from gastric adenocarcinoma usually occurs in the setting of hepatic nodal or…”
Get full text

Turmeric Induced Liver Injury: A Report of Two Cases by Majid, Ammar A., Roberts, Stuart K., Schneider, Hans G., Aung, Ar Kar, Pope, Jeffrey D., Lontos, Steve, Rentsch, Clarissa, Luber, Raphael P., Kemp, William

“…Turmeric is a commonly used oral herbal supplement with purported anti-inflammatory and antineoplastic properties. It is promoted as safe, with limited reports…”
Get full text

Sa1882 SWITCHING INFLIXIMAB BIOSIMILAR: NO ADVERSE IMPACT ON IBD CONTROL OR DRUG LEVELS WITH FIRST OR SECOND SWITCH by Luber, Raphael P., O'Neill, Rhona, Singh, Sukhpreet, Arkir, Zehra, Irving, Peter M.

Get full text

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease by Rentsch, Clarissa A., Ward, Mark G., Luber, Raphael P., Taylor, Kirstin M., Gibson, David J., Headon, Belinda, Rosella, Ourania, Su, Heidi Y., Friedman, Antony B., Dooley, Michael, Sparrow, Miles P., Gibson, Peter R.

Get full text

1134: PRE-OPERATIVE ORAL ENTERAL NUTRITIONAL OPTIMISATION FOR CROHN'S DISEASE: A RETROSPECTIVE UK TERTIARY IBD CENTRE COHORT STUDY by Meade, Susanna, Patel, Kamal V, Luber, Raphael P, O'Hanlon, Dearbhaile, Caracostea, Andra, Pavlidis, Polychronis, Honap, Sailish, Anandarajah, Cheran, Griffin, Nyree, Zeki, Sebastian, Ray, Shuvra, Mawdsley, Joel, Anderson, Simon H., Samaan, Mark A., Darakhshan, Amir, Adams, Katie, Williams, Andrew B., Sanderson, Jeremy D, Lomer, Miranda, Irving, Peter M.

Get full text